Skip to content

Impella 0550-0008

by Abiomed, Inc.

Impella 0550-0008 is a Class III device made by Abiomed, Inc., approved under FDA PMA P140003 on 23 Mar 2015 and listed in FDA GUDID since 15 Apr 2020 (UDI-DI 00813502011531), active as of 22 Oct 2026. 24 FDA recalls are linked to it.

Active United States. Also listed in GUDID (US).

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

21 ongoing

This device is named in the recall

Documents

PMA P140003

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00813502011531 UDI-DI Date15 Apr 2020ListedStatusListed GUDID: in commercial distribution
United StatesFDA PMAAPPR from GUDID Approved NumberP140003 Date23 Mar 2015DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA PMA P140003 decided 23 Mar 2015 Active
  • FDA GUDID UDI-DI 00813502011531 listed 15 Apr 2020 Listed

Recalls

25 recalls · 21 ongoing · FDA

  • 3 recalls, same reason

    • Ongoing Z-0209-2027 FDA Not yet classified initiated 18 Sep 2026
    • Ongoing Z-0210-2027 FDA Not yet classified initiated 18 Sep 2026
    • Ongoing Z-0208-2027 FDA Not yet classified initiated 18 Sep 2026

    Retrospective review of servicing records identified AIC units requiring various hardware, firmware, and/or software update(s): 1. RFID firmware issue that may result in failure of the AIC to recognize the purge cassette during case setup or cassette change. This issue may result in delay in procedure or therapy. 2. Potential for the rotary push button (RPB) sticking and unreliable actuation impacting operator ability to select and confirm menu entries. This can result in loss of control of the console. 3. Potential AIC instability that could result in AIC start-up failure, inability to drive the pump, and the need for console exchange. 4. Software defect related to calculator process crash, leading to Negative Central Venous Pressure (CVP) values present in Pulmonary Artery Pressure (PAP) calculations.

  • 3 recalls, same reason

    • Ongoing Z-3148-2026 FDA Class I initiated 12 Aug 2026
    • Ongoing Z-3149-2026 FDA Class I initiated 12 Aug 2026
    • Ongoing Z-3150-2026 FDA Class I initiated 12 Aug 2026

    The potential for purge cassette recognition issues due to the failure of the purge flag component of the purge pressure sensor assembly.

    • Ongoing Z-2457-2026 FDA Class I initiated 18 May 2026

    Exposure to the low purge pressure occurrence may result in persistent low purge pressure alarms and, in some cases, interruption or loss of mechanical circulatory support.

    • Ongoing Z-2360-2026 FDA Class I initiated 14 May 2026

    Potential software error in the Automated Impella Controller ("AIC" ) when used in conjunction with left ventricular Impella devices.

    • Ongoing Z-2211-2026 FDA Class I initiated 20 Apr 2026

    A retrospective review identified that there are AIC units requiring specific hardware updates to address potential safety concerns. These hardware updates have been implemented through Abiomed s servicing process; therefore, AICs that have not received service are pending these updates. Issue 1: The proximity of the internal Video Graphics Array cable to the Digital Signal Processor chipset on the Impellatronic printed circuit assembly could potentially result in Electrostatic Discharge coupling into the Digital Signal Processor which may interrupt motor controls. Issue 2: There is a potential for the Compact Flash Memory Card dislodgement due to external applied forces, which could result in AIC startup failures and data logging issues. Issue 3: Improper routing of the fan wire within the AIC could lead to fan wire damage, which may result in console boot-up failure. Issue 4: Potential capacitor related issues on the Power Battery Manager, including the potential for the capacitors to cause pump stop, purge stop, and/or single fan fuse failures.

    • Ongoing Z-1589-2026 FDA Class I initiated 18 Feb 2026

    Increased risk of purge leaks with Generation 1 purge cassettes.

    • Ongoing Z-1591-2026 FDA Class I initiated 16 Feb 2026

    Potential that the "Purge System Blocked" alarm display on the Automated Impella Controller (AIC) could be delayed when using first generation Impella 5.5 (0550-0008*) pumps.

    • Ongoing Z-1030-2026 FDA Class II initiated 4 Dec 2025

    Device packaged in incorrect outer box carton.

    • Ongoing Z-0069-2026 FDA Class I initiated 1 Oct 2025

    Potential cybersecurity vulnerabilities related to the operating system in the Automated Impella Controller (AIC).

    • Ongoing Z-0136-2026 FDA Class I initiated 16 Sep 2025

    Potential for Automated Impella Controller (AIC) purge pressure issues due to purge retainer failures.

    • Ongoing Z-2164-2025 FDA Class I initiated 23 Jun 2025

    A potential issue with the Automated Impella Controller (AIC) not detecting an Impella pump when it is connected

    • Ongoing Z-2319-2024 FDA Class I initiated 31 May 2024

    Nine (9) Impella CP pumps failed inspection and were inadvertently released.

    • Ongoing Z-0980-2024 FDA Class I initiated 27 Dec 2023

    IFU has been updated to include warnings about the risk of the inlet perforating through the myocardial wall of the left ventricle due to operator handling.

    • Ongoing Z-0636-2024 FDA Class II initiated 6 Dec 2023 on shared PMA P140003

    The following features have been disabled from the web-based portal because the FDA has not evaluated these features for safety and effectiveness: Notifications via email feature; AIC alarm color on case tile feature; Sort case tiles by AIC alarm color feature; Pump metric display on case tile feature

    • Ongoing Z-1590-2023 FDA Class I initiated 17 Apr 2023

    The Impella 5.5 pump experienced a heightened complaint rate for purge leaks.

    • Ongoing Z-3251-2026 FDA Class II initiated 19 Feb 2019

    Retrospective report of issues remedied in 2019 with firmware and software patches: 1. Defects in optical bench (OPB) firmware V2.19, which affected the accuracy and stability of the pressure signal the AIC system performance depends on. 2. Software defects leading to unreliable or missing placement signal, unresponsive start Impella soft key during disconnect/reconnect, and false Position in Ventricle alarm in certain AICs.

    • Ongoing Z-2238-2026 FDA Class I initiated 17 Jan 2011

    Retrospective submission for following issues identified: 1. Alarm failures, power-path faults, electrical-short risks, and inaccurate motor-current sensing were identified in certain AIC consoles. 2. There is improper alignment between the purge cassette and the motor drive in the AIC. This can result in a piston block event and lead to the inability to complete priming of the purge system, requiring the user to switch to backup AIC console.

  • 2 recalls, same reason

    • Terminated Z-0440-2024 FDA Class II initiated 10 Oct 2023
    • Terminated Z-0441-2024 FDA Class II initiated 10 Oct 2023

    Pump not detected as connected to controller due to software issue.

    • Terminated Z-1175-2024 FDA Class II initiated 1 Mar 2021

    Retrospective reporting for the release of Technical Bulletin IMP-2643 AIC Version 8.5 Software Update Available. The update resolved an issue in version 8.4 where a pump was not recognized by the AIC.

    • Terminated Z-0345-2020 FDA Class II initiated 4 Sep 2019

    This one pump shipped with incorrect pump programming, the initial production working version of the program. The pump would have immediately run at P9 for all selected P-levels, rather than a 10 second ramp up period. The pump may have migrated out of position and possibly caused injury. The positioning and suction alarms were also disabled.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Timeline

27 dated events

  1. Recall initiated FDA recalls Z-1589-2026
  2. Recall initiated FDA recalls Z-2211-2026
  3. Recall initiated FDA recalls Z-2360-2026
  4. Recall initiated FDA recalls Z-2457-2026
  5. Recall initiated FDA recalls Z-3148-2026
  6. Recall initiated FDA recalls Z-3149-2026
  7. Recall initiated FDA recalls Z-3150-2026
  8. Recall initiated FDA recalls Z-0209-2027
  9. Recall initiated FDA recalls Z-0210-2027
  10. Recall initiated FDA recalls Z-0208-2027

17 earlier events are in the sections above.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

GUDID

Trade name
Impella
Generic name
Intracardiac circulatory assist axial-pump catheter
Model / Ref / Catalog
0550-0008
Primary DI / UDI-DI
00813502011531
PMA number
FDA product code
OZD
GMDN term
Intracardiac circulatory assist axial-pump catheter
Device class
Class III
GUDID distribution status
In Commercial Distribution

Other devices from Abiomed, Inc.

See all devices from Abiomed, Inc. →

Properties

  • Supplied sterile
  • Single use
  • Contains latex
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Serial number
  • Expiration date
Other properties (7, all answered No)